【24h】

The Janus-faced aspect of 'dry weight'.

机译:“干重”的贾努斯面。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: The goal of haemodialysis treatment in end-stage renal disease (ESRD) patients is to correct the complications of the uraemic condition. Among the main complications are fluid overload and subsequent hypertension that are corrected by achievement of 'dry weight'. We report in this study the evolution of post-dialysis body-weight and blood pressure in patients who began their HD treatment in our unit. METHODS: We studied the monthly evolution of post-dialysis body-weight (expressed as a percentage of pre-dialysis body-weight at the first HD treatment) and predialysis mean arterial pressure (MAP) over 24 months in 61 patients (21 females, mean age 59.8 years; 20% diabetic), treated with cellulosic membranes for 8 h, 3 times a week. RESULTS: The post-dialysis body-weight decreased between the onset of HD and month 2 (M2) (-4.40+/-0.52%). Then it went up, reaching -1.56+/-0.96% at M6, +0.3+/-1.27% at M12, +1.27+/-1.38% at M18 and +1.64+/-1.33% at M24. The post-dialysis body-weight increased by 6% between M2 and M24. The mean arterial pressure (MAP) decreased from 111.3+/-2.5 mmHg at M0 to 94.4+/-1.7 at M6, and then remained stable after M6. Between M2 and M6 the post-dialysis body-weight increased, whereas the predialysis MAP continued to decline. The incidence of hypotension episodes was maximal during the first 4 months of HD treatment. CONCLUSIONS: After the second month of dialysis treatment, the simultaneous increase of post-dialysis body-weight and decrease of pre-dialysis MAP are related to the effects of two processes, i.e. increased weight as the result of anabolism induced by the HD treatment on the one hand and normalization of blood pressure by fluid removal on the other. Continuous clinical assessment of the patient is necessary to provide adequate prescription of post-dialysis body-weight. During the first months of HD treatment, the nephrologist, like Janus, is a double-faced gatekeeper: he must be willing to decrease post-dialysis weight to achieve 'dry weight' and to normalize blood pressure, but he must also be prepared to increase it to compensate for anabolism and to avoid episodes of hypotension.
机译:背景:终末期肾脏疾病(ESRD)患者的血液透析治疗的目标是纠正尿毒症的并发症。主要并发症包括体液超负荷和随后的高血压,这些症状可通过实现“干重”来纠正。我们在这项研究中报告了在我们单位开始进行HD治疗的患者的透析后体重和血压的变化。方法:我们研究了61位患者(21位女性,24位女性)在24个月内的透析后体重(表示为首次HD治疗时透析前体重的百分比)和透析前平均动脉压(MAP)的每月变化。平均年龄59.8岁; 20%患有糖尿病),每周3次用纤维素膜处理8小时。结果:透析后的体重在HD发作到第2个月(M2)之间下降(-4.40 +/- 0.52%)。然后上升,在M6达到-1.56 +/- 0.96%,在M12达到+0.3 +/- 1.27%,在M18达到+1.27 +/- 1.38%,在M24达到+1.64 +/- 1.33%。 M2和M24之间,透析后体重增加了6%。平均动脉压(MAP)从M0时的111.3 +/- 2.5 mmHg降低到M6时的94.4 +/- 1.7,然后在M6之后保持稳定。在M2和M6之间,透析后体重增加,而透析前MAP继续下降。在HD治疗的前4个月,低血压发作的发生率最高。结论:透析治疗第二个月后,透析后体重的同时增加和透析前MAP的降低与两个过程的影响有关,即HD治疗引起的合成代谢导致体重增加。一方面通过去除液体使血压正常化。要提供足够的透析后体重处方,必须对患者进行连续的临床评估。在HD治疗的最初几个月中,肾脏病学家和Janus一样,是双重的看门人:他必须愿意降低透析后的体重以达到“干重”并使血压正常化,但他也必须做好准备增加它以补偿合成代谢并避免低血压发作。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号